Rankings
▼
Calendar
AUPH Q4 2016 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
AUPH
Aurinia Pharmaceuticals Inc.
$2B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$30,000
Gross Profit
$29,000
96.7% margin
Operating Income
-$8M
-26750.0% margin
Net Income
-$8M
-27776.7% margin
EPS (Diluted)
$-0.15
QoQ Revenue Growth
-3.2%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$356,000
Balance Sheet
Total Assets
$57M
Total Liabilities
$21M
Stockholders' Equity
$36M
Cash & Equivalents
$40M
← FY 2016
All Quarters
Q1 2017 →
